Publication | Open Access
2-Aminobenzophenones as a Novel Class of Bradykinin B<sub>1</sub>Receptor Antagonists
16
Citations
0
References
2008
Year
Selective bradykinin (BK) B 1 receptor antagonists could be novel therapeutic agents for the treatment of pain and inflammation. Elucidation of the structure activity relationships of the structurally novel HTS lead compound 1 provided potent hBK B 1 receptor antagonists with excellent receptor occupancy in the CNS of hBK B 1 transgenic rats.